Lowenstein Sandler, which has a heavy presence in New Jersey, on Wednesday said Kevin Colan has joined the firm as partner in its Tax practice.
Colan will be based in the firm’s New York office.
Colan works with clients to devise effective tax strategies for successful mergers, acquisitions, and dispositions of public and private companies, as well as strategic investments and joint ventures. His practice focuses on protecting his clients’ interests in strategic transactions and creating innovative tax structuring solutions that support their overall financial and business goals.
Working closely with investment managers and their principals, Colan also structures funds focused on private equity, credit, real estate, infrastructure and other alternative asset classes and advises on the structuring and financing of investments by these funds.
“I was attracted by Lowenstein’s vision, commitment to innovation, and its agility to adapt to a rapidly changing economic environment,” Colan said. “The firm has demonstrated remarkable success in key growth practices, like private equity, ECVC, and life sciences, and is structured to represent client companies from early financing through a liquidity event and beyond. There is a collective sense of direction and ambition amongst all the attorneys with whom I’ve met across all Lowenstein practices, and that really excites me.”
“Not only does Kevin’s knowledge of the tax aspects of complex investment transactions perfectly meet the needs of our clients, but his approach to the practice of law is closely aligned with our firm’s core values. We attract lawyers seeking a collegial and collaborative culture: our close-knit partnership fosters real relationships and provides each partner with the opportunity to have a meaningful voice,” Brian Silikovitz, chair of Lowenstein’s Tax practice, said.
In addition to his previous roles in private practice at Clifford Chance, Paul Weiss, and Simpson Thacher, Colan served as a Special Agent in the Federal Bureau of Investigation, where he principally investigated health care and securities fraud. He received his J.D. from Harvard Law and his B.S. from Dartmouth.
